JP2006519254A5 - - Google Patents

Download PDF

Info

Publication number
JP2006519254A5
JP2006519254A5 JP2006507651A JP2006507651A JP2006519254A5 JP 2006519254 A5 JP2006519254 A5 JP 2006519254A5 JP 2006507651 A JP2006507651 A JP 2006507651A JP 2006507651 A JP2006507651 A JP 2006507651A JP 2006519254 A5 JP2006519254 A5 JP 2006519254A5
Authority
JP
Japan
Prior art keywords
chondrogenesis
excipient
carrier
compound
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006507651A
Other languages
English (en)
Other versions
JP2006519254A (ja
Filing date
Publication date
Priority claimed from AU2003901023A external-priority patent/AU2003901023A0/en
Application filed filed Critical
Publication of JP2006519254A publication Critical patent/JP2006519254A/ja
Publication of JP2006519254A5 publication Critical patent/JP2006519254A5/ja
Withdrawn legal-status Critical Current

Links

Claims (1)

  1. 下記式の化合物(1):
    Figure 2006519254
    を担体または賦形剤との混合物として含む軟骨形成分化誘導用薬剤組成物。
JP2006507651A 2003-03-04 2004-03-01 軟骨形成分化誘導用非免疫抑制ピペコリン酸誘導体類の用途 Withdrawn JP2006519254A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003901023A AU2003901023A0 (en) 2003-03-04 2003-03-04 New use
PCT/JP2004/002502 WO2004078167A1 (en) 2003-03-04 2004-03-01 Use of non-immunosuppressive pipecolic acid derivatives for inducing chondrogenic differentiation

Publications (2)

Publication Number Publication Date
JP2006519254A JP2006519254A (ja) 2006-08-24
JP2006519254A5 true JP2006519254A5 (ja) 2007-03-22

Family

ID=31500068

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507651A Withdrawn JP2006519254A (ja) 2003-03-04 2004-03-01 軟骨形成分化誘導用非免疫抑制ピペコリン酸誘導体類の用途

Country Status (10)

Country Link
US (1) US20060199832A1 (ja)
EP (1) EP1599195A1 (ja)
JP (1) JP2006519254A (ja)
KR (1) KR20050109952A (ja)
CN (1) CN1756540A (ja)
AU (1) AU2003901023A0 (ja)
CA (1) CA2518100A1 (ja)
MX (1) MXPA05009317A (ja)
TW (1) TW200507827A (ja)
WO (1) WO2004078167A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009089549A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0346427B1 (en) * 1987-12-09 1995-03-29 FISONS plc Macrocyclic compounds
GR1001225B (el) * 1989-09-14 1993-06-30 Fisons Plc Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους.
US5912224A (en) * 1996-02-22 1999-06-15 The General Hospital Corporation Methods and compositions for enhancing cellular response to TGF-β ligands
AUPQ078799A0 (en) * 1999-06-04 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. New use
GB9917158D0 (en) * 1999-07-21 1999-09-22 Fujisawa Pharmaceutical Co New use
AR035411A1 (es) * 2000-12-29 2004-05-26 Fujisawa Pharmaceutical Co Uso de un derivado de tacrolimus para fabricar un agente neurotrofico, composiciones y articulos de fabricacion o kits que lo comprenden, metodo para fabricar un agente que lo comprende y tejidos e injertos con una celula nerviosa tratada con este compuesto

Similar Documents

Publication Publication Date Title
JP2007522220A5 (ja)
JP2006526031A5 (ja)
JP2005518413A5 (ja)
JP2006514012A5 (ja)
JP2009545527A5 (ja)
JP2009502743A5 (ja)
JP2010511721A5 (ja)
EP2332904A3 (en) Derivatives of tetracycline compounds
JP2010501534A5 (ja)
JP2009535462A5 (ja)
JP2012506896A5 (ja)
JP2009502793A5 (ja)
JP2005526011A5 (ja)
EP2292209A3 (en) Stable pharmaceutical composition comprising a pyramidine-sulfamide
JP2008506632A5 (ja)
JP2007534702A5 (ja)
EP1961748A3 (en) 2-Hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors
JP2020097577A5 (ja)
JP2006505543A5 (ja)
JP2008520662A5 (ja)
JP2009536221A5 (ja)
EP2404912A3 (en) Process and intermediates for the preparation of antitumoral dihydropyran-2-one compounds
JP2008524312A5 (ja)
JP2010507590A5 (ja)
JP2006518752A5 (ja)